Atlas Trials

A Phase 1 Study To Investigate The Pharmacokinetics, Safety And Tolerability Of CP-601,927 In Healthy Japanese Subjects

Clinical trial NCT01396135 · WITHDRAWN

Trial details

NCT number
NCT01396135
Sponsor
Pfizer
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2011-08-26
Primary completion
2011-10-29
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.